Hill-Rom Holdings, Inc. (HRC) Shares Sold by American International Group Inc.

American International Group Inc. lessened its stake in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 3.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 133,209 shares of the medical technology company’s stock after selling 4,172 shares during the period. American International Group Inc.’s holdings in Hill-Rom were worth $14,102,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund lifted its stake in Hill-Rom by 8,755.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 2,308,056 shares of the medical technology company’s stock valued at $26,000 after acquiring an additional 2,281,991 shares during the period. Norges Bank acquired a new stake in Hill-Rom during the 4th quarter valued at approximately $66,335,000. Bank of New York Mellon Corp lifted its stake in Hill-Rom by 27.0% during the 4th quarter. Bank of New York Mellon Corp now owns 1,038,521 shares of the medical technology company’s stock valued at $91,961,000 after acquiring an additional 220,981 shares during the period. BlackRock Inc. lifted its stake in Hill-Rom by 3.5% during the 4th quarter. BlackRock Inc. now owns 6,350,899 shares of the medical technology company’s stock valued at $562,371,000 after acquiring an additional 215,770 shares during the period. Finally, Two Sigma Investments LP lifted its stake in Hill-Rom by 260.1% during the 4th quarter. Two Sigma Investments LP now owns 255,055 shares of the medical technology company’s stock valued at $22,585,000 after acquiring an additional 184,230 shares during the period. 84.76% of the stock is currently owned by institutional investors.

HRC opened at $99.10 on Friday. The company has a quick ratio of 1.27, a current ratio of 1.69 and a debt-to-equity ratio of 1.10. Hill-Rom Holdings, Inc. has a 1 year low of $81.82 and a 1 year high of $108.68. The firm has a market capitalization of $6.56 billion, a P/E ratio of 20.86, a PEG ratio of 1.68 and a beta of 0.91.

Hill-Rom (NYSE:HRC) last posted its earnings results on Friday, April 26th. The medical technology company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.03. Hill-Rom had a net margin of 7.93% and a return on equity of 21.30%. The firm had revenue of $714.20 million during the quarter, compared to analysts’ expectations of $705.59 million. During the same period in the previous year, the business posted $1.05 EPS. The business’s revenue was up .5% compared to the same quarter last year. As a group, equities research analysts forecast that Hill-Rom Holdings, Inc. will post 5.05 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 21st will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend is Thursday, June 20th. Hill-Rom’s dividend payout ratio is currently 17.68%.

Several brokerages have commented on HRC. Zacks Investment Research upgraded shares of Hill-Rom from a “sell” rating to a “hold” rating in a research note on Tuesday, February 12th. Barclays lifted their price objective on shares of Hill-Rom from $103.00 to $108.00 and gave the company an “equal weight” rating in a research note on Monday, April 15th. Needham & Company LLC restated a “buy” rating and set a $116.00 price objective on shares of Hill-Rom in a research note on Monday, March 11th. Finally, ValuEngine cut shares of Hill-Rom from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $109.88.

TRADEMARK VIOLATION NOTICE: This story was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/05/17/hill-rom-holdings-inc-hrc-shares-sold-by-american-international-group-inc.html.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Further Reading: What is Put Option Volume?

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.